Table 4.

Data about the correlation between SES and patient and graft survival, patient compliance and complications in liver transplant recipients

	SES
	Low (n=216)	High (n=62)	p
Graft failure. (%/n)
Clinical	19.4 (42)	19.4 (12)	0.987
Pathologic	3.7 (8)	4.8 (3)	0.713
Clinicopathologic	9.3 (20)	14.5 (9)	0.233
Death (%/n)	23.6 (51)	19.4 (12)	0.480
Died >100 days	9.3 (20)	4.8 (3)	0.265
Cause of death (%/n)	10.2 (22)	6.5 (4)	0.373
Infection	7.4 (16)	3.2 (6)	0.380
Cardiac	2.8 (6)	3.2 (2)	1.000
Respiratory	3.2 (7)	6.5 (4)	0.271
Other
Complications(%/n)	85.6 (185)	91.9 (57)	0.194
Surgical	17.1 (37)	17.7 (11)	0.910
Metabolic	57.4 (124)	66.1 (41)	0.218
Neurologic	19.0 (41)	24.2 (15)	0.367
Cardiac	25.9 (56)	21.0 (13)	0.426
Infection	63.4 (137)	62.9 (39)	0.940
Neoplasia	6.9 (15)	9.7 (6)	0.470
Other	64.8 (140)	56.5 (35)	0.229
Vascular	22.2 (48)	19.4 (12)	0.629
GIS	58.3 (126)	50.0 (31)	0.243
Rheumatologic	6.0 (13)	3.2 (2)	0.534
Biliary	19.0 (41)	22.6 (14)	0.531
Incisional hernia (%/n)	9.7 (21)	8.1 (5)	0.693
Less work act.(%/n)	60.2 (130)	51.6 (32)	0.228
Follow up (days/months) (meant±SD)	1283.7±788.4 (0–2679)	1347.5±771.6 (0–2552)	0.569
Primary (%/n) recurrent disease	42.7±26.2 (0–89.3)	44.9±25.7 (0–85.1)	0.571
Post-transplant (%/n) serology (+) continue	10.2 (22)	19.4 (12)	0.052
Immunosup (%/n)	12.0 (26)	21.0 (13)	0.074
ineffective/adv eff	10.6 (23)	12.9 (8)	0.619
Reperfusion synd.	7.4 (16)	4.8 (3)	0.581
Preservation damage	3.7 (8)	1.6 (1)	0.689